Cargando…

Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?

Detalles Bibliográficos
Autores principales: Yalta, K, Sivri, N, Geyik, B, Aksoy, Y, Yetkin, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721299/
https://www.ncbi.nlm.nih.gov/pubmed/22447478
_version_ 1782278059289739264
author Yalta, K
Sivri, N
Geyik, B
Aksoy, Y
Yetkin, E
author_facet Yalta, K
Sivri, N
Geyik, B
Aksoy, Y
Yetkin, E
author_sort Yalta, K
collection PubMed
description
format Online
Article
Text
id pubmed-3721299
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-37212992013-08-07 Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked? Yalta, K Sivri, N Geyik, B Aksoy, Y Yetkin, E Cardiovasc J Afr Letter to the Editor Clinics Cardive Publishing 2012-03 /pmc/articles/PMC3721299/ /pubmed/22447478 Text en Copyright © 2010 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Yalta, K
Sivri, N
Geyik, B
Aksoy, Y
Yetkin, E
Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
title Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
title_full Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
title_fullStr Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
title_full_unstemmed Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
title_short Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
title_sort sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721299/
https://www.ncbi.nlm.nih.gov/pubmed/22447478
work_keys_str_mv AT yaltak suddencardiacdeathduetob2agonisttherapyisageneticbasisoverlooked
AT sivrin suddencardiacdeathduetob2agonisttherapyisageneticbasisoverlooked
AT geyikb suddencardiacdeathduetob2agonisttherapyisageneticbasisoverlooked
AT aksoyy suddencardiacdeathduetob2agonisttherapyisageneticbasisoverlooked
AT yetkine suddencardiacdeathduetob2agonisttherapyisageneticbasisoverlooked